Matched paired analysis of AML patients revealed identical IDH1 mutations in diagnosis versus relapse samples demonstrating the conservation of IDH1 mutations in LSCs which drive disease relapse (69). This evidence concerns the gene IDH1 and acute myeloid leukemia.